Financial updates
Pharming announces Agenda for its Capital Markets Briefing to be held on 21 June 2018 in New York
Pharming Group N.V. announces the agenda for its Capital Markets Briefing to be held from 08:00 to 10:30 EST/14:00-16:30 CET on 21 June 2018 in New York, NY, and through a live webcast.
- New forms of administration for RUCONEST® for HAE
- Expansion of rhC1INH clinical development in pre-eclampsia, contrast induced nephropathy and other potential large indications
- Clinical development of protein replacement products in Pompe and Fabry diseases